Cyclotene
CAS 80-71-7
Cyclotene (CAS 80-71-7) is a pharmaceutical compound with 0 bioactivity targets and 101 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Cyclotene is linked to DTXSID4035128 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Cyclotene used for in pharmaceutical contexts?
Cyclotene (CAS 80-71-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Cyclotene?
Cyclotene has 101 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Acute kidney injury, Alanine aminotransferase increased, Anaemia, Arrhythmia, Aspartate aminotransferase increased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Cyclotene also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for METHYLCYCLOPENTENOLONE with EU status "permitted".
What clinical phase is Cyclotene in?
No phase 1-4 clinical development badge is rendered for Cyclotene because the matched compound identifier rows do not contain a max-phase value.